Best Stocks Under $3 | Low-Priced Stocks for $3 or Less

1. Galiano Gold NYSEAMERICAN:GAU

$2.11 +0.01 (+0.48%)

Closing price 04:10 PM Eastern

Extended Trading

$2.10 -0.01 (-0.71%)

As of 07:37 PM Eastern

Galiano Gold Inc engages in the exploration and evaluation of gold properties in Canada. Its flagship asset is the Asanko Gold Mine that covers an area of approximately 21,000 hectares located in Ghana, West Africa. More about Galiano Gold

Market Capitalization: $552.93 million
P/E Ratio: 8.12
Consensus Rating: Buy
Consensus Price Target: $3.85 (+82.5% Upside)
Volume: 1.82 million shares
Average Volume: 3.19 million shares

2. Ur Energy NYSEAMERICAN:URG

$0.92 +0.02 (+2.33%)

Closing price 04:10 PM Eastern

Extended Trading

$0.92 +0.01 (+0.62%)

As of 07:57 PM Eastern

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization: $366.16 million
Consensus Rating: Buy
Consensus Price Target: $2.23 (+143.2% Upside)
Volume: 9.94 million shares
Average Volume: 9.35 million shares
Today's Range: $0.87
▼
$0.93

3. Stereotaxis NYSEAMERICAN:STXS

$0.97 -0.06 (-5.80%)

Closing price 04:10 PM Eastern

Extended Trading

$1.00 +0.03 (+3.06%)

As of 07:30 PM Eastern

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. More about Stereotaxis

Market Capitalization: $97.22 million
Consensus Rating: Buy
Consensus Price Target: $3.50 (+260.7% Upside)
Volume: 309,526 shares
Average Volume: 590,924 shares
Today's Range: $0.97
▼
$1.04

4. iBio NASDAQ:IBIO

$0.80 +0.04 (+4.86%)

Closing price 04:00 PM Eastern

Extended Trading

$0.82 +0.02 (+2.34%)

As of 07:30 PM Eastern

iBio, Inc, a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. More about iBio

Market Capitalization: $51.72 million
Consensus Rating: Buy
Consensus Price Target: $6.00 (+646.1% Upside)
Volume: 280,881 shares
Average Volume: 1.10 million shares
Today's Range: $0.74
▼
$0.81

5. Palisade Bio NASDAQ:PALI

$1.19 -0.01 (-0.83%)

Closing price 04:00 PM Eastern

Extended Trading

$1.20 +0.02 (+1.26%)

As of 07:43 PM Eastern

Palisade Bio, Inc, a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. More about Palisade Bio

Market Capitalization: $207.38 million
Consensus Rating: Buy
Consensus Price Target: $9.29 (+680.3% Upside)
Volume: 15.11 million shares
Average Volume: 3.59 million shares
Today's Range: $1.10
▼
$1.22

6. Niagen Bioscience NASDAQ:NAGE

$2.54 +0.04 (+1.60%)

Closing price 04:00 PM Eastern

Extended Trading

$2.54 +0.00 (+0.16%)

As of 07:30 PM Eastern

Niagen Bioscience, Inc is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. More about Niagen Bioscience

Market Capitalization: $202.29 million
P/E Ratio: 14.11
Consensus Rating: Buy
Consensus Price Target: $10.33 (+306.8% Upside)
Volume: 363,912 shares
Average Volume: 845,741 shares

7. Compugen NASDAQ:CGEN

$2.01 +0.04 (+2.03%)

Closing price 04:00 PM Eastern

Extended Trading

$2.02 +0.01 (+0.50%)

As of 07:31 PM Eastern

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. More about Compugen

Market Capitalization: $190.05 million
P/E Ratio: 5.29
Consensus Rating: Buy
Consensus Price Target: $5.00 (+148.8% Upside)
Volume: 149,142 shares
Average Volume: 362,827 shares

8. Grab NASDAQ:GRAB

$2.75 +0.03 (+1.10%)

Closing price 04:00 PM Eastern

Extended Trading

$2.74 -0.02 (-0.55%)

As of 07:59 PM Eastern

Grab Holdings Limited engages in the provision of superapps in Cambodia, Indonesia, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam. More about Grab

Market Capitalization: $11.27 billion
P/E Ratio: 45.84
Consensus Rating: Buy
Consensus Price Target: $5.91 (+114.7% Upside)
Volume: 55.07 million shares
Average Volume: 52.78 million shares

9. Larimar Therapeutics NASDAQ:LRMR

$2.54 +0.15 (+6.28%)

Closing price 04:00 PM Eastern

Extended Trading

$2.56 +0.02 (+0.94%)

As of 07:55 PM Eastern

Larimar Therapeutics, Inc, a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. More about Larimar Therapeutics

Market Capitalization: $263.86 million
Consensus Rating: Buy
Consensus Price Target: $10.33 (+306.8% Upside)
Volume: 809,780 shares
Average Volume: 2.44 million shares
Today's Range: $2.31
▼
$2.55

10. Ovid Therapeutics NASDAQ:OVID

$2.45 +0.19 (+8.41%)

Closing price 04:00 PM Eastern

Extended Trading

$2.46 +0.01 (+0.45%)

As of 07:56 PM Eastern

Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid Therapeutics

Market Capitalization: $478.49 million
Consensus Rating: Moderate Buy
Consensus Price Target: $6.00 (+144.9% Upside)
Volume: 2.05 million shares
Average Volume: 2.29 million shares
Today's Range: $2.21
▼
$2.49

11. Perspective Therapeutics NYSEAMERICAN:CATX

$1.25 +0.06 (+5.04%)

Closing price 04:10 PM Eastern

Extended Trading

$1.25 0.00 (-0.40%)

As of 07:59 PM Eastern

Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective Therapeutics

Market Capitalization: $142.69 million
Consensus Rating: Moderate Buy
Consensus Price Target: $10.50 (+740.0% Upside)
Volume: 4.59 million shares
Average Volume: 2.29 million shares
Today's Range: $1.07
▼
$1.25

12. Equillium NASDAQ:EQ

$1.42 +0.06 (+4.41%)

Closing price 04:00 PM Eastern

Extended Trading

$1.42 0.00 (0.00%)

As of 07:30 PM Eastern

Equillium, Inc, a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. More about Equillium

Market Capitalization: $90.04 million
Consensus Rating: Moderate Buy
Consensus Price Target: $7.57 (+433.2% Upside)
Volume: 227,351 shares
Average Volume: 620,405 shares
Today's Range: $1.36
▼
$1.43

13. Inhibikase Therapeutics NASDAQ:IKT

$1.62 +0.05 (+3.18%)

Closing price 04:00 PM Eastern

Extended Trading

$1.62 +0.00 (+0.31%)

As of 07:30 PM Eastern

Inhibikase Therapeutics, Inc, a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. More about Inhibikase Therapeutics

Market Capitalization: $226.05 million
Consensus Rating: Moderate Buy
Consensus Price Target: $4.75 (+193.2% Upside)
Volume: 386,645 shares
Average Volume: 1.08 million shares
Today's Range: $1.53
▼
$1.63

14. Cabaletta Bio NASDAQ:CABA

$1.52 +0.07 (+4.47%)

Closing price 04:00 PM Eastern

Extended Trading

$1.50 -0.02 (-1.18%)

As of 07:49 PM Eastern

Cabaletta Bio, Inc, a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. More about Cabaletta Bio

Market Capitalization: $257.70 million
Consensus Rating: Moderate Buy
Consensus Price Target: $15.60 (+926.3% Upside)
Volume: 5.83 million shares
Average Volume: 4.18 million shares
Today's Range: $1.42
▼
$1.53

15. Tvardi Therapeutics NASDAQ:TVRD

$0.89 +0.02 (+2.53%)

Closing price 04:00 PM Eastern

Extended Trading

$0.90 +0.01 (+0.99%)

As of 07:59 PM Eastern

Cara Therapeutics, Inc, an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. More about Tvardi Therapeutics

Market Capitalization: $11.84 million
Consensus Rating: Moderate Buy
Consensus Price Target: $9.40 (+959.5% Upside)
Volume: 86,098 shares
Average Volume: 775,441 shares
Today's Range: $0.84
▼
$0.93

16. Gold Royalty NYSEAMERICAN:GROY

$2.90 0.00 (0.00%)

Closing price 04:10 PM Eastern

Extended Trading

$2.92 +0.02 (+0.86%)

As of 07:56 PM Eastern

Gold Royalty Corp., a precious metals-focused royalty company, provides financing solutions to the metals and mining industry. More about Gold Royalty

Market Capitalization: $669.35 million
P/E Ratio: 290.29
Consensus Rating: Moderate Buy
Consensus Price Target: $5.38 (+85.3% Upside)
Volume: 722,967 shares
Average Volume: 2.36 million shares

17. Tenaya Therapeutics NASDAQ:TNYA

$0.40 +0.00 (+0.60%)

Closing price 04:00 PM Eastern

Extended Trading

$0.41 +0.01 (+1.29%)

As of 07:57 PM Eastern

Tenaya Therapeutics, Inc, a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. More about Tenaya Therapeutics

Market Capitalization: $90.54 million
Consensus Rating: Moderate Buy
Consensus Price Target: $4.00 (+890.6% Upside)
Volume: 1.20 million shares
Average Volume: 3.49 million shares
Today's Range: $0.40
▼
$0.41

18. Nkarta NASDAQ:NKTX

$1.72 +0.02 (+1.18%)

Closing price 04:00 PM Eastern

Extended Trading

$1.73 +0.01 (+0.35%)

As of 07:55 PM Eastern

Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. More about Nkarta

Market Capitalization: $123.19 million
Consensus Rating: Moderate Buy
Consensus Price Target: $11.20 (+551.2% Upside)
Volume: 1.05 million shares
Average Volume: 757,357 shares
Today's Range: $1.63
▼
$1.73

19. Autolus Therapeutics NASDAQ:AUTL

$1.63 +0.08 (+5.16%)

Closing price 04:00 PM Eastern

Extended Trading

$1.60 -0.03 (-2.09%)

As of 07:30 PM Eastern

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases. More about Autolus Therapeutics

Market Capitalization: $433.84 million
Consensus Rating: Moderate Buy
Consensus Price Target: $10.00 (+513.5% Upside)
Volume: 1.39 million shares
Average Volume: 1.79 million shares
Today's Range: $1.52
▼
$1.64

20. Banco Bradesco NYSE:BBDO

$2.57 -0.19 (-6.88%)

Closing price 03:59 PM Eastern

Extended Trading

$2.58 +0.01 (+0.39%)

As of 07:50 PM Eastern

Banco Bradesco SA, together with its subsidiaries, provides various banking products and services to individuals, corporates, and businesses in Brazil and internationally. More about Banco Bradesco

Market Capitalization: $27.23 billion
P/E Ratio: 5.59
Consensus Rating: Moderate Buy
Consensus Price Target: $73.58 (+2,763.2% Upside)
Volume: 284,161 shares
Average Volume: 84,562 shares

21. Tritax Big Box REIT OTCMKTS:TTBXF

$1.95 0.00 (0.00%)

As of 10/27/2026

Tritax Big Box REIT plc (ticker: BBOX) is the largest listed investor in high-quality logistics warehouse assets and controls the largest logistics-focused land platform in the UK. More about Tritax Big Box REIT

Market Capitalization: $5.27 billion
Consensus Rating: Moderate Buy
Average Volume: 6,306 shares
Today's Range: $1.95
▼
$1.95
50-Day Range: $1.61
▼
$2.06
52-Week Range: $1.61
▼
$2.43

22. NervGen Pharma NASDAQ:NGEN

$1.50 +0.02 (+1.35%)

Closing price 04:00 PM Eastern

Extended Trading

$1.49 -0.01 (-0.67%)

As of 07:30 PM Eastern

NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. More about NervGen Pharma

Market Capitalization: $120.95 million
Consensus Rating: Moderate Buy
Consensus Price Target: $14.00 (+833.3% Upside)
Volume: 309,239 shares
Average Volume: 505,610 shares
Today's Range: $1.45
▼
$1.55

23. CytomX Therapeutics NASDAQ:CTMX

$2.36 +0.05 (+2.16%)

Closing price 04:00 PM Eastern

Extended Trading

$2.36 0.00 (-0.21%)

As of 07:30 PM Eastern

CytomX Therapeutics, Inc, an oncology-focused biopharmaceutical company, focuses on developing novel conditionally activated biologics localized to the tumor microenvironment. More about CytomX Therapeutics

Market Capitalization: $514.24 million
Consensus Rating: Moderate Buy
Consensus Price Target: $11.90 (+404.2% Upside)
Volume: 4.08 million shares
Average Volume: 4.66 million shares
Today's Range: $2.25
▼
$2.39

24. BridgeBio Oncology Therapeutics NASDAQ:BBOT

$2.80 +0.11 (+4.09%)

Closing price 04:00 PM Eastern

Extended Trading

$2.70 -0.10 (-3.54%)

As of 07:30 PM Eastern

We are a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. More about BridgeBio Oncology Therapeutics

Market Capitalization: $224.49 million
Consensus Rating: Moderate Buy
Consensus Price Target: $21.11 (+654.0% Upside)
Volume: 482,179 shares
Average Volume: 421,394 shares
Today's Range: $2.61
▼
$2.86

25. Data I/O NASDAQ:DAIO

$2.52 +0.08 (+3.28%)

Closing price 04:00 PM Eastern

Extended Trading

$2.46 -0.06 (-2.58%)

As of 06:14 PM Eastern

Data I/O Corporation, together with its subsidiaries, engages in the design, manufacture, and sale of programming and security deployment systems and services for electronic device manufacturers in the United States, Europe, and internationally. More about Data I/O

Market Capitalization: $26.20 million
Consensus Rating: Moderate Buy
Consensus Price Target: $5.11 (+102.8% Upside)
Volume: 17,458 shares
Average Volume: 45,741 shares
Today's Range: $2.45
▼
$2.69

Best Stocks Under $3 Right Now

1. Galiano Gold NYSEAMERICAN:GAU

2. Ur Energy NYSEAMERICAN:URG

3. Stereotaxis NYSEAMERICAN:STXS

4. iBio NASDAQ:IBIO

5. Palisade Bio NASDAQ:PALI

6. Niagen Bioscience NASDAQ:NAGE

7. Compugen NASDAQ:CGEN

8. Grab NASDAQ:GRAB

9. Larimar Therapeutics NASDAQ:LRMR

10. Ovid Therapeutics NASDAQ:OVID

11. Perspective Therapeutics NYSEAMERICAN:CATX

12. Equillium NASDAQ:EQ

13. Inhibikase Therapeutics NASDAQ:IKT

14. Cabaletta Bio NASDAQ:CABA

15. Tvardi Therapeutics NASDAQ:TVRD

16. Gold Royalty NYSEAMERICAN:GROY

17. Tenaya Therapeutics NASDAQ:TNYA

18. Nkarta NASDAQ:NKTX

19. Autolus Therapeutics NASDAQ:AUTL

20. Banco Bradesco NYSE:BBDO

21. Tritax Big Box REIT OTCMKTS:TTBXF

22. NervGen Pharma NASDAQ:NGEN

23. CytomX Therapeutics NASDAQ:CTMX

24. BridgeBio Oncology Therapeutics NASDAQ:BBOT

25. Data I/O NASDAQ:DAIO

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Best Stocks Under $3 Right Now

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools